Subscribe To
Why is kala pharmaceuticals (kala) stock soaring 240%?
Amid another soft performance for the benchmark equities index, rare-eye disease specialist Kala Pharmaceuticals (NASDAQ: KALA ) lit up the overcast s...
December 28, 2022, 1:14 pm
Opus genetics announces acquisition of the rights to two gene therapy product candidates for inherited retinal diseases
Opus to advance preclinical development programs for BEST1– and RHO-related retinal diseases Deal expands Opus’ addressable patient population for...
December 28, 2022, 1:00 pm
Zymeworks (zyme) stock up 29% in three months: here's why
Zymeworks (ZYME) recently entered a collaboration with Jazz Pharmaceuticals (JAZZ) for its lead pipeline candi...
December 28, 2022, 12:21 pm
Kala pharmaceuticals (kala) up as fda accepts ind for kpi-012
The FDA accepts Kala Pharmaceuticals' (KALA) investigational new drug application for pipeline candidat...
December 28, 2022, 12:21 pm
Why did immutep ltd stock soar recently?
Analysts and investors alike appear enamored with Immutep Ltd, whose earnings are growing; more of which could come from their latest product ...
December 28, 2022, 2:01 am
Jefferies analyst reveals his top two biotech stocks for 2023
Moderna Inc (NASDAQ: MRNA) has tanked nearly 15% in recent days but a Jefferies analyst dubs it one of his best ideas for 2023. Moderna stock could cl...
December 27, 2022, 7:26 pm
4 unstoppable multibaggers to buy in 2023 and hold for the next decade
Three-year revenue growth rates between 39% and 54% are projected, making these stocks prime multibagger candi...
December 27, 2022, 5:57 am
Madrigal pharmaceuticals setting the standard
Madrigal's lead drug candidate was already expected to be successful in its pivotal trial. FDA approval...
December 26, 2022, 12:36 pm
Terns announces closing of public offering of shares of common stock, including full exercise of underwriters’ option to purchase additional shares
FOSTER CITY, Calif., Dec. 23, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
December 23, 2022, 9:05 pm
Why dbv technologies stock is soaring today
The company can now move forward with a late-stage study of its lead pipeline candidate....
December 23, 2022, 12:01 pm
Oric's stock rallies on multiple myeloma deal with pfizer
Shares of Oric Pharmaceuticals Inc. ORIC, +2.04% soared about 56% in premarket trading on Thursday, the day after the company said it will collaborate...
December 22, 2022, 8:38 am
Avidity biosciences: unique antibody-oligonucleotide conjugate technology
Avidity Biosciences' stock was up 55% last week after releasing preliminary data from a Phase 1/ 2 study of its antibody-oligonucleotide technology ...
December 22, 2022, 5:22 am
Magenta (mgta) down on pipeline update for leukemia drug
Magenta Therapeutics (MGTA) stops dosing participants in a phase I/II study cohort, evaluating its blood cancer pipeline ...
December 21, 2022, 9:02 am
Pfizer submits colitis drug application to fda, ema
Pfizer Inc. PFE, -0.08% said Wednesday that the Food and Drug Administration and the European Medicines Agency accepted the new drug application for i...
December 21, 2022, 7:45 am
Poolbeg pharma identifies possible new rsv treatments as infection rates soar
Poolbeg Pharma said it had identified five potential new drug candidates from its Respiratory Syncytial...
December 21, 2022, 2:32 am
Terns announces pricing of $75 million public offering
FOSTER CITY, Calif., Dec. 20, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stag...
December 21, 2022, 12:40 am
Lianbio (lian) up after pfizer opts in rights to rsv drug in china
As a result of Pfizer's (PFE) opt-in for LianBio's (LIAN) rights to develop RSV therapeutic candidate s...
December 20, 2022, 12:02 pm
The bullish case for teladoc
Investing in Teladoc Health, Inc. is a contrarian call. Sentiment is deep-negative. The firm faces a lot of competition, but actually enjoys even more...
December 19, 2022, 2:52 pm
Madrigal’s stock rallies about 200% after sharing positive data about its nash treatment candidate
Shares of Madrigal Pharmaceuticals Inc. soared 209.6% in premarket trading on Monday after the company shared positive data from a pivotal Phase 3 cli...
December 19, 2022, 1:07 pm
Fortress biotech appoints lucy lu, m.d., to its board of directors
MIAMI, Dec. 19, 2022 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on e...
December 19, 2022, 1:00 pm